REGN - Regeneron Pharmaceuticals, Inc.
Stock Analysis
Data: 2026-02-03us_universe.csv
- 2025IPOs.csv
- tb_sch.csv
- test_small.csv
- us_AI.csv
- us_cpu.csv
- us_Nuclear.csv
- us_penny_100.csv
- us_penny.csv
- us_Quantum.csv
- us_universe.csv
Last updated: Feb 03, 2026 at 7:03 PMFresh
show_chart Price & Trend 797.91 • 52W 476.49 - 807.83
Volume
Close
EMA9
MA50
MA150
MA200
Breakout
MA200 Reclaim
MA50 Touch
Pocket Pivot
PB Bounce
EMA9 Cross
auto_graph Pattern Recognition
info
info
Moderate pattern consistency: 59% win rate.
Signal Success Rate
59%
94 total signals
Avg Gain on Winners
+4.8%
55 wins
Avg Loss on Losers
-4.1%
39 losses
Recurring Behaviors
trending_up
Tendency to go on win streaks (longest: 10 signals in a row)
trending_down
Warning: Can experience losing streaks (longest: 6 signals)
Best Signal Type
MA50Touch
10 signals • 70% win rate
Avg gain: +1.4%
Worst Signal Type
Breakout
12 signals • 50% win rate
Avg loss: 0.3%
All Signal Types (Best ? Worst)
MA50Touch
70%
10 signals
+1.4%
MA200Reclaim
67%
6 signals
+1.9%
PullbackBounce
58%
19 signals
+1.5%
PocketPivot
57%
47 signals
+1.0%
Breakout
50%
12 signals
+0.3%
Trading Insights
lightbulb
Focus on MA50Touch signals - 70% win rate.
Swing Cycle Analysis
Dominant pattern: ±3% every ~2.0 days (strength 0.30)
No consistent swing rhythm detected — observed ±3% fluctuations appear irregular or noise-driven.
Swing activity (±3% over ~2.0 days) is present but weak — slight downward bias (more troughs than peaks); pattern confidence is low.
| Swing | Avg Days | Strength | Pattern? |
|---|---|---|---|
| 3% | 2.0 | 0.30 Weak+ | ? |
| 1% | 0.0 | 0.00 Weak | — |
| 2% | 0.0 | 0.00 Weak | — |
? Trough
? Peak(turning points)
No consistent swing rhythm detected — observed ±3% fluctuations appear irregular or noise-driven.
assessment Key Metrics Universe Updated
Price
$797.91
Score
U
0.696
RS 6M
U
94
RS 3M
U
98
description Recommendation Summary
Buy
Confidence: 10/10
Performance: B+ Good
R/C: 0.15:1
BUY (Confidence: 10/10) - Breakout Candidate | Strong Uptrend (Stage 2) | Explosive Momentum (Elite) | R/R 0.15:1 (Risk 8.0%) | Avoid/Extended
Trend
Strong Uptrend (Stage 2)
Momentum
Explosive Momentum (Elite)
Setup Type
Breakout Candidate
grade Absolute Rating
Strong Buy
Standalone Technical Quality
check_circle
Trend Strength (Price > MA50, proper stack) (2 points)
check_circle
13W Return ? +20% (2 points)
check_circle
4W Return ? +8% (1 points)
check_circle
Up/Down Volume ? 1.10 (1 points)
check_circle
ATR(20) ? 3.5% (1 points)
cancel
Within 5%-25% of 52W High (0 points)
cancel
Risk/Reward ? 2:1 (R/R 0.15:1) (0 points)
Future Analytics
Coming soon...
security Risk Management
Suggested Stop Loss
$734.07
8.0% riskPotential Upside
+1.2%
R/R: 0.1:1Expected Move (20 d, ATR Proxy)
±$79.02 (9.9%)
Range: $718.88 - $876.93insights What It Means
The stock shows a mix of technical characteristics with strong relative strength and a solid composite score. Some developing risks (e.g., Stretched above MA200 +32%) to monitor. Risk/Reward moderate (~0.2:1); catalysts or consolidation may improve it.
Positives
check_circle
Strong relative strength (RS6M 94, RS3M 98)
check_circle
Absolute rating Strong Buy
check_circle
Perfect moving average stack (healthy uptrend)
check_circle
Accumulation (Up/Down Vol 1.40)
Negatives / Risks
warning
Stretched above MA200 +32%
thumb_up Bullish Factors 9
check_circle
Elite 6m RS: 94th percentile (top 6%)
check_circle
Elite 3m RS: 98th percentile (top 2%)
check_circle
Accelerating momentum (3m > 6m RS)
check_circle
Perfect MA stack (MA50 > MA150 > MA200)
check_circle
Price above all major MAs (strong trend)
check_circle
Strong accumulation: 1.40x up/down volume
check_circle
Strong 1-week gain: +3.1%
check_circle
Near 52-week high: -1.2% off peak
check_circle
Risk/Reward: 0.15:1 (Risk 8.0%, Reward 1.2% )
thumb_down Bearish Factors 1
cancel
Suboptimal R/R (<1:1)
analytics Technical Indicators
Current Price
$797.91
MA 50
$723.24
10.3%MA 150
$613.42
30.1%MA 200
$606.06
31.7%News & Sentiment
Last updated Feb 03 19:03
Sentiment line (?1..+1) with scaled article volume bars (height relative to sentiment range). Rolling 7d average smooths trend.
Positive day
Negative day
Neutral
Sentiment
7d Avg
Avg 7d: +0.12
Articles 7d: 56
Latest: +0.16 (8)Peak: +0.21 Jan 31
The Truth About Regeneron Pharmaceuticals Inc: Why Wall Street Will Not Shut Up About REGN - AD HOC NEWS
"REGN stock" - Google News
Feb 03 3:37 PM
0.00
The Truth About Regeneron Pharmaceuticals Inc: Why Wall Street Will Not Shut Up About REGN AD HOC NEWS
A Quick Look at Today's Ratings for Regeneron Pharmaceuticals(REGN.US), With a Forecast Between $742 to $950 - 富途牛牛
"REGN stock" - Google News
Feb 03 5:53 AM
0.00
A Quick Look at Today's Ratings for Regeneron Pharmaceuticals(REGN.US), With a Forecast Between $742 to $950 富途牛牛
Analysts Are Bullish on These Healthcare Stocks: Regeneron (REGN), Praxis Precision Medicines (PRAX) - The Globe and Mail
"REGN stock" - Google News
Feb 03 5:44 AM
+0.20
Analysts Are Bullish on These Healthcare Stocks: Regeneron (REGN), Praxis Precision Medicines (PRAX) The Globe and Mail
Scotiabank Reaffirms Their Hold Rating on Regeneron (REGN) - The Globe and Mail
"REGN stock" - Google News
Feb 03 5:14 AM
0.00
Scotiabank Reaffirms Their Hold Rating on Regeneron (REGN) The Globe and Mail
Feb 02, 2026 BMO Maintains Outperform on REGN (Regeneron Pharmaceuticals, Inc.) - Meyka
"REGN stock" - Google News
Feb 03 2:03 AM
+0.10
Feb 02, 2026 BMO Maintains Outperform on REGN (Regeneron Pharmaceuticals, Inc.) Meyka
Which Is a Better Investment, Arrowhead Pharmaceuticals, Inc. or Regeneron Pharmaceuticals, Inc. Stock?
REGN stock - BingNews
Feb 03 1:08 AM
0.00
Learn more about whether Arrowhead Pharmaceuticals, Inc. or Regeneron Pharmaceuticals, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial ...
Analysts Are Bullish on These Healthcare Stocks: Regeneron (REGN), Praxis Precision Medicines (PRAX)
REGN stock - BingNews
Feb 02 11:36 PM
+0.20
According to TipRanks.com, Brisebois is a 1-star analyst with an average return of -1.4% and a 36.6% success rate. Brisebois covers the Healthcare sector, focusing on stocks such as Centessa ...
Does Modest 2025 Results and New EYLEA HD Data Shift the Bull Case for Regeneron (REGN)? - simplywall.st
"REGN stock" - Google News
Feb 02 5:30 PM
+0.10
Does Modest 2025 Results and New EYLEA HD Data Shift the Bull Case for Regeneron (REGN)? simplywall.st
Regeneron Pharmaceuticals, Inc. (REGN) Stock Analysis: A Promising 15% Upside as Analysts Rally Behind Biotech Giant - DirectorsTalk Interviews
"REGN stock" - Google News
Feb 02 2:54 PM
+0.10
Regeneron Pharmaceuticals, Inc. (REGN) Stock Analysis: A Promising 15% Upside as Analysts Rally Behind Biotech Giant DirectorsTalk Interviews
JP Morgan Raises Price Target for REGN to $950 | REGN Stock News - GuruFocus
"REGN stock" - Google News
Feb 02 11:09 AM
0.00
JP Morgan Raises Price Target for REGN to $950 | REGN Stock News GuruFocus
Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target Raised to $950.00 at JPMorgan Chase & Co. - MarketBeat
"REGN stock" - Google News
Feb 02 10:45 AM
+0.10
Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target Raised to $950.00 at JPMorgan Chase & Co. MarketBeat
Regeneron Pharmaceuticals (REGN) Gets Analyst Boost with Revised Price Target | REGN Stock News - GuruFocus
"REGN stock" - Google News
Feb 02 10:10 AM
0.00
Regeneron Pharmaceuticals (REGN) Gets Analyst Boost with Revised Price Target | REGN Stock News GuruFocus
Oppenheimer Reaffirms Outperform Rating for Regeneron Pharmaceuticals (NASDAQ:REGN) - MarketBeat
"REGN stock" - Google News
Feb 02 10:07 AM
+0.20
Oppenheimer Reaffirms Outperform Rating for Regeneron Pharmaceuticals (NASDAQ:REGN) MarketBeat
Peering Into Regeneron Pharmaceuticals Inc's Recent Short Interest - Benzinga
"REGN stock" - Google News
Feb 02 10:00 AM
0.00
Peering Into Regeneron Pharmaceuticals Inc's Recent Short Interest Benzinga
Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target Raised to $769.00 at Morgan Stanley - MarketBeat
"REGN stock" - Google News
Feb 02 9:45 AM
+0.10
Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target Raised to $769.00 at Morgan Stanley MarketBeat
Analyst Matthew Harrison Maintains Equal-Weight Rating for REGN | REGN Stock News - GuruFocus
"REGN stock" - Google News
Feb 02 9:12 AM
0.00
Analyst Matthew Harrison Maintains Equal-Weight Rating for REGN | REGN Stock News GuruFocus
Wells Fargo Raises Price Target for Regeneron Pharmaceuticals (R - GuruFocus
"REGN stock" - Google News
Feb 02 8:13 AM
0.00
Wells Fargo Raises Price Target for Regeneron Pharmaceuticals (R GuruFocus
REGN: Cantor Fitzgerald Raises Price Target to $800, Maintains O - GuruFocus
"REGN stock" - Google News
Feb 02 8:13 AM
0.00
REGN: Cantor Fitzgerald Raises Price Target to $800, Maintains O GuruFocus
Cantor Fitzgerald Issues Positive Forecast for Regeneron Pharmaceuticals (NASDAQ:REGN) Stock Price - MarketBeat
"REGN stock" - Google News
Feb 02 7:55 AM
+0.10
Cantor Fitzgerald Issues Positive Forecast for Regeneron Pharmaceuticals (NASDAQ:REGN) Stock Price MarketBeat
Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target Raised to $800.00 - MarketBeat
"REGN stock" - Google News
Feb 02 7:55 AM
+0.10
Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target Raised to $800.00 MarketBeat
Truist Financial Has Lowered Expectations for Regeneron Pharmaceuticals (NASDAQ:REGN) Stock Price - MarketBeat
"REGN stock" - Google News
Feb 02 7:21 AM
+0.10
Truist Financial Has Lowered Expectations for Regeneron Pharmaceuticals (NASDAQ:REGN) Stock Price MarketBeat
Truist Securities Maintains Buy Rating on REGN, Lowers Price Tar - GuruFocus
"REGN stock" - Google News
Feb 02 7:14 AM
0.00
Truist Securities Maintains Buy Rating on REGN, Lowers Price Tar GuruFocus
Regeneron (REGN) Boosts Dividend by 6.8%, Expects Strong Growth - GuruFocus
"REGN stock" - Google News
Feb 02 6:08 AM
+0.20
Regeneron (REGN) Boosts Dividend by 6.8%, Expects Strong Growth GuruFocus
Cantor Fitzgerald raises Regeneron stock price target to $800 on portfolio outlook - Investing.com
"REGN stock" - Google News
Feb 02 5:22 AM
0.00
Cantor Fitzgerald raises Regeneron stock price target to $800 on portfolio outlook Investing.com
Eye drug EYLEA HD offers fewer eye injections in fresh trial data - Stock Titan
"REGN stock" - Google News
Feb 02 4:00 AM
0.00
Eye drug EYLEA HD offers fewer eye injections in fresh trial data Stock Titan
AE Wealth Management LLC Buys 1,371 Shares of Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
"REGN stock" - Google News
Feb 02 2:51 AM
+0.10
AE Wealth Management LLC Buys 1,371 Shares of Regeneron Pharmaceuticals, Inc. $REGN MarketBeat
Regeneron stock slips premarket even after Wall Street lifts targets on strong Q4 — what’s weighing on the stock?
REGN stock - BingNews
Feb 01 5:09 PM
+0.10
Several Wall Street firms raised price targets on Regeneron after its Q4 results. ・Q4 revenue and non-GAAP earnings both exceeded Wall Street estimates. ・Eylea HD sales rose sharply, while sales of ...
Regeneron Pipeline Progress And Valuation Gap Put Future Growth In Focus
REGN stock - BingNews
Feb 01 3:26 AM
+0.10
Regeneron Pharmaceuticals (NasdaqGS:REGN) is highlighting progress across its product pipeline, with management pointing to expectations for at least four upcoming FDA approvals. The company is ...
Stock Scanner
- scienceTestingkeyboard_arrow_down
Stock Scanner v1.0.0
Copyright Ⓒ 2025